Trulieve Cannabis Corp Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $1.1B-4.0% YoYTTM through 30 Jun 2026
Net Income -$476.2MTTM through 30 Jun 2026
Free Cash Flow $182.8MTTM through 30 Jun 2026
Margins
| Current | |
|---|---|
| Gross Margin | 59.3% |
| EBITDA Margin | -14.3% |
| Operating Margin | 12.5% |
| Net Margin | -41.8% |
Returns
0.2%ROE
0.1%ROA
Balance Sheet Health
Debt / Equity0.25x
Current Ratio5.26x
Net Debt-$62.9Mnet cash position
Cash & Equivalents$325.4M
Quality Metrics
Altman Z-Score0.59
Piotroski F-Score4 / 9
FCF Margin16.0%
Earnings-Beat Rate75.0%
Multi-Year Trend
RevenueFY2025: $1.2B
Diluted EPSFY2022: $-1.34
Dividend
No dividend
Capital Allocation
Capex Intensity5.4%
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.